Search

everythinglearnresearchcommunity

for

Search:↓

Psychological interventions can improve mental health and quality of life in people with alopecia.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Topical eye β-blockers may cause hair loss.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

People with alopecia areata may have a higher risk of hearing loss.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

A specific gene variant may increase the risk of developing Alopecia Areata.

Patients with alopecia areata face high costs for wigs due to poor insurance coverage.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Thymoma may link myasthenia gravis, nail dystrophy, and alopecia areata.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

People with alopecia areata may have a higher risk of thyroid diseases.

Alopecia areata significantly affects mental health and quality of life, with many feeling stigma and few receiving adequate treatment.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.